Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Alset EHome International | AEI | Nov 22, 2024 | 1.08 | -1.82 |
Alt5 Sigma | ALTS | Nov 22, 2024 | 2.19 | +1.86 |
Alta Equipment A Pref | ALTG-A | Nov 22, 2024 | 25.47 | -1.09 |
Alta Equipment Group A | ALTG | Nov 22, 2024 | 7.91 | +5.33 |
Alta Global Group | MMA | Nov 22, 2024 | 1.67 | -7.51 |
Altair Engineering A | ALTR | Nov 22, 2024 | 105.20 | +0.81 |
Altamira Therapeutics | CYTO | Nov 22, 2024 | 0.42 | -3.31 |
AltEnergy Acquisition A | AEAE | Nov 22, 2024 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Nov 22, 2024 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | Nov 22, 2024 | 1.07 | 0.00 |
Alternus Clean Energy A | ALCE | Nov 22, 2024 | 1.36 | -4.90 |
Alti Global A | ALTI | Nov 22, 2024 | 4.31 | +0.47 |
Altice USA A | ATUS | Nov 22, 2024 | 2.59 | 0.00 |
Altimmune | ALT | Nov 22, 2024 | 8.68 | +3.27 |
Altisource Portfolio Solutions | ASPS | Nov 22, 2024 | 0.76 | +1.98 |
Alto Ingredients | ALTO | Nov 22, 2024 | 1.42 | 0.00 |
Alto Neuroscience | ANRO | Nov 22, 2024 | 4.31 | +5.38 |
Altria Group | MO | Nov 22, 2024 | 56.73 | +1.25 |
Altus Power A | AMPS | Nov 22, 2024 | 4.17 | +2.71 |
Alumis | ALMS | Nov 22, 2024 | 9.46 | +0.21 |
Alvotech | ALVO | Nov 22, 2024 | 11.99 | -3.62 |
ALX Oncology | ALXO | Nov 22, 2024 | 1.41 | +9.30 |
Alzamend Neuro | ALZN | Nov 22, 2024 | 1.31 | +0.77 |
Amalgamated Financial | AMAL | Nov 22, 2024 | 36.51 | +1.36 |
Amarin ADR | AMRN | Nov 22, 2024 | 0.55 | +4.52 |
Amazon.com | AMZN | Nov 22, 2024 | 197.12 | -0.64 |
Ambac Financial Group | AMBC | Nov 22, 2024 | 12.55 | +1.95 |
Ambarella | AMBA | Nov 22, 2024 | 63.62 | +3.78 |
Ambev ADR | ABEV | Nov 22, 2024 | 2.19 | +1.86 |
Ambipar Emergency Response | AMBI | Nov 22, 2024 | 5.09 | -1.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.